LIVE MARKET TRACKER :   BSE SENSEX   27458.64      |    NSE NIFTY 8341.40    
GLOBAL MARKETS :  NASDAQ 4863.36   -0.27%    |    FSI London 6862.80   -0.47%    |    NIKKEI Japan 19285.63   -0.95%
  USD GBP EUR CAD AUD INR
USD - 0.6723 0.9244 1.2518 1.2830 62.6080
GBP 1.4880 - 1.3754 1.8630 1.9096 93.1482
EUR 1.0820 0.7272 - 1.3545 1.3883 67.7337
CAD 0.7993 0.5370 0.7389 - 1.0252 50.0424
AUD 0.7796 0.5240 0.7206 0.9760 - 48.8086
INR 0.0160 0.0107 0.0148 0.0200 0.0205 -
Indian-Commodity  :  Corporate  :  GlaxoSmithkline Consumer Healthcare reports 18% rise in Q4 net profit

GlaxoSmithkline Consumer Healthcare reports 18% rise in Q4 net profit (16-Feb-2013)

GlaxoSmithkline Consumer Healthcare has reported results for fourth quarter and for the year ended December 31, 2012.

The company has reported 17.85% rise in its net profit at Rs 69.65 crore for the quarter as compared to Rs 59.10 crore for the same quarter in the previous year. Total income of the company has increased by 18.27% at Rs 769.62 crore for quarter under review as compared to Rs 650.70 crore for the quarter ended December 31, 2011.

For the year ended December 31, 2012, the company has posted a rise of 22.96% in its net profit at Rs 436.77 crore as compared to Rs 355.21 crore for the same period in the previous year. Total income from operation has increased by 15.82% at Rs 3301.29 crore for year under review as compared to Rs 2850.26 crore for the period ended December 31, 2011.


Top News Today
Government to collect initial upfront payment of Rs 28,872 crore of spectrum auctions
(27-Mar-2015)

Government to collect initial upfront payment of Rs 28,872 crore of spectrum auctionsThe government after getting a go ahead from the Supreme Court declared the winners of the recently concluded airwaves auction. Now the government can collect initial upfront payment of Rs 28,872 crore......click on news to read complete article.

Cadila Healthcare, Bharti Airtel and Idea Cellular to see some action today
(27-Mar-2015)

Cadila Healthcare, Bharti Airtel and Idea Cellular to see some action todayCadila Healthcare has purchased 50% shares of Zydus BSV Pharma from Bharat Serums and Vaccines and now Zydus BSV has become 100% subsidiary of Cadila Healthcare. Zydus Cadila is an innovative, global pharmaceutical......click on news to read complete article.

Govt to step up public spending on infrastructure, ease entry barriers for overseas investors
(26-Mar-2015)

Govt to step up public spending on infrastructure, ease entry barriers for overseas investorsFinance Minister Arun Jaitley has expressed his concern over slow growth of manufacturing sector and promised to step up public spending on infrastructure, ease entry barriers for overseas investors and......click on news to read complete article.

International Stock News
US markets closed lower for fourth straight session
(27-Mar-2015)

US markets closed lower for fourth straight sessionThe US market closed lower on Thursday, declining for the fourth consecutive session, with the benchmark S&P 500 turning negative for the year and recording its longest losing streak since January.......click on news to read complete article.

US markets closed lower; S&P, Dow marks sharpest losses in two weeks
(26-Mar-2015)

US markets closed lower; S&P, Dow marks sharpest losses in two weeksThe US market closed lower on Tuesday, with Nasdaq Composite suffering its steepest decline since April 2014, as investors' dumped technology and biotech shares. The carnage on the Street marks the third......click on news to read complete article.

US markets closed lower as rate hikes loom
(25-Mar-2015)

US markets closed lower as rate hikes loomThe US market closed lower on Tuesday, as investors grappled with a batch of better-than-expected economic reports that suggest a rate hike may be nearing. In a sign that the core of the Federal Reserve......click on news to read complete article.

 

     
  
Recent Corporate News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.